Vaccine Delivery Devices Market To Witness Growth Based On Growing Immunization Programs & Their Increasing Coverage Till 2025:Grand View Research,inc.
The global vaccine delivery devices market is expected to
reach USD 6.21 billion by 2025, according to a new report by Grand View
Research, Inc. The market is primarily driven by growing immunization programs,
financial support from government & nongovernment organizations, increasing
vaccination initiatives & campaigns, and rising prevalence of infectious
diseases globally. Growing research in the field of vaccines and development of
new products is also contributing to the growth of the market.
Adoption of needle-free approach
for administering these products is gaining momentum due to growing awareness
and demand to avoid pain & injuries associated with the use of a needle
stick. Data by the Centers for Disease Control and Prevention states that an
estimated 385,000 sharp injuries including needle stick injuries occur every
year in hospitals in the U.S. Advancing technologies in administering vaccines
and their increasing adoption is propelling market growth. Rising interest of
various key players, national institutions, and organizations in novel delivery
technologies is expected to further contribute to market growth.
Various governments and
international organizations are increasingly investing in the development of
vaccination programs. For instance, the UK government also announced funding up
to £1 million from its Global Challenges Research Fund through Medical Research
Council to investigate the Zika virus and its transmission. Organizations such
as GAVI Alliance, Bill & Melinda Gates Foundation, Path, and WHO are
actively involved in the field of vaccines. Many governments are also
undertaking several immunization programs on priority.
Vaccine delivery devices market, by device, 2014 - 2025
(USD Million)
Browse full research report on Vaccine
Delivery Devices Market
Further key findings from the report suggest:
- The syringes
segment held majority of the revenue share in 2016 due to increasing
vaccination programs, spreading immunization coverage, and technological
advancements
- Jet injectors
is expected to register highest growth during the forecast period owing to
rising concerns regarding needle stick injuries and growing preference for
needle-free technologies
- Intramuscular
vaccination dominated the route of administration segment in 2016 as
majority of vaccines are given through this route owing to its advantages
- North America
dominated the global market owing to increasing awareness levels, high
adoption of technology, and rising prevalence of infectious diseases
- Some of the
key players include Becton Dickinson & Company, Bioject Medical
Technologies, Inc. (Inovio Pharmaceutical Inc.); Gerresheimer AG;
PharmaJet; Corium International, Inc.; and SCHOTT AG
For more information: http://www.grandviewresearch.com
Comments
Post a Comment